Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Jazz Pharmaceuticals plc | d280908d8k.htm |
Exhibit 99.1
Transcript of the relevant portion of the conference call held by Jazz Pharmaceuticals, Inc.
4:30pm EST, January 5, 2012
[Kate Falberg, Senior Vice President and Chief Financial Officer, Jazz Pharmaceuticals, Inc.]
Turning to the balance sheet, we and Azur Pharma estimate that we ended 2011 with a combined cash balance of close to $240 million and no debt.